LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

First Steps toward Personalized Therapies for ABCA3 Deficiency

Photo by gabiontheroad from unsplash

The ABCA3 (ATP-binding cassette transporter A3) protein transports phospholipids from the cytoplasm into lamellar bodies in alveolar type II cells (AEC2s) and is critical for pulmonary surfactant synthesis and function.… Click to show full abstract

The ABCA3 (ATP-binding cassette transporter A3) protein transports phospholipids from the cytoplasm into lamellar bodies in alveolar type II cells (AEC2s) and is critical for pulmonary surfactant synthesis and function. Biallelic pathogenic ABCA3 variants cause diverse pulmonary phenotypes, including lethal neonatal respiratory distress syndrome, childhood interstitial lung disease, and idiopathic pulmonary fi brosis Current therapies, including steroids, fi c ef fi cacy transplantation fi

Keywords: first steps; steps toward; therapies abca3; toward personalized; personalized therapies; abca3 deficiency

Journal Title: American Journal of Respiratory Cell and Molecular Biology
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.